Pharmaceutical Technology
DECEMBER 19, 2023
Pharmaceutical Technology outlines some of the biggest US Food and Drug Administration (FDA) drug approvals announced in 2023 that are set to make an impact in the coming years.
Bio Pharma Dive
DECEMBER 19, 2023
The biotechnology company’s share price fell more than 10% Tuesday after the disclosure of more data from a small study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
DECEMBER 19, 2023
Sanofi and Innate’s cancer collaboration agreement stretches back to 2016, with two of Sanofi’s NK cell engagers in clinical studies.
Bio Pharma Dive
DECEMBER 19, 2023
The company’s shot targets 21 strains of pneumococcal bacteria and, if approved, would compete with Pfizer’s Prevnar 20.
Pharmaceutical Technology
DECEMBER 19, 2023
Kronos Bio is prioritising its multiple myeloma therapy after reviewing negative Phase Ib AML data for lanraplenib.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 19, 2023
Just as the shift to shorter days and colder weather can bring with it mood swings and other emotional challenges, the holiday season can also bring about somewhat predictable changes in mood and behavior. Around this time of year, many of us experience more stress, anxiety and frustration than usual.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 19, 2023
The Pharmacy Council of India (PCI) has requested all pharmacy institutions to fill the correct data as per Aadhaar card details in the Standard Inspection Format (SIF) and PCI portal as part of its process of integrating Aadhaar authentication for the faculties, pharmacists, students and pharmacy institutions in the portal as per the recent notification […]
Bio Pharma Dive
DECEMBER 19, 2023
The new guidelines may give regulators more ammunition to go after vertical and cross-market M&A that has historically been more difficult to challenge.
Pharmaceutical Technology
DECEMBER 19, 2023
In this issue: Fixing drug nomenclature to avoid confusing names, gene therapies for sickle cell disease, childproof packaging for drugs, and UK pharma manufacturing gears up for a shake up in 2024
Fierce Pharma
DECEMBER 19, 2023
On the market for two decades for asthma, Novartis and Roche’s Xolair is closing in on a new indication as a way for those with food allergies to avoid severe outcomes. | On the market for two decades for asthma, Novartis and Roche’s Xolair is closing in on a new indication as a way for those with food allergies to avoid severe outcomes. The agency granted a priority review to Roche's filing and plans to make a decision during the first quarter of next year.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
DECEMBER 19, 2023
Last month, Vertex Pharmaceuticals and CRISPR Therapeutics made history, by gaining approval for the first clustered regularly interspaced short palindromic repeats (CRISPR)-based drug, exagamglogene autotemcel (Casgevy).
Fierce Pharma
DECEMBER 19, 2023
A German court has dealt the first blow against CureVac amid the company's heated COVID-19 vaccine patent fight with fellow German mRNA specialist BioNTech. | A German court has dealt the first blow against CureVac amid the company's heated COVID-19 vaccine patent fight with fellow German mRNA specialist BioNTech.
Pharmaceutical Technology
DECEMBER 19, 2023
Super pollutants like black carbon found their way onto the agenda of COP28, which hosted the annual conference's first 'Health Day'
Drug Discovery World
DECEMBER 19, 2023
The first patient has been dosed with an engineered B cell investigational therapy in a Phase I trial in Mucopolysaccharidosis type I (MPS I). Developer Immusoft has received FDA Orphan Drug Designation and Rare Pediatric Disease Designation for the therapy, designated ISP-001, in this indication. MPS I is a rare, genetic disease that affects the body’s ability to produce the enzyme alpha-L-iduronidase (IDUA).
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
DECEMBER 19, 2023
The FDA has requested information on long-term potency after the Phase II trial was put on clinical hold due to manufacturing issues in 2022.
Outsourcing Pharma
DECEMBER 19, 2023
The US Food and Drug Administration (FDA) has approved a topical foam developed by Arcutis Biotherapeutics and branded as Zoryve for the skin condition seborrheic dermatitis in people aged nine years and up.
Pharmaceutical Technology
DECEMBER 19, 2023
The EC has granted approval for Merck’s (MSD) anti-PD-1 therapy, Keytruda, plus chemotherapy for two indications in gastrointestinal cancers.
BioSpace
DECEMBER 19, 2023
The biotech’s investigational COMP360 psilocybin treatment showed positive safety and tolerability with no serious adverse events in a mid-stage study of people with post-traumatic stress disorder.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
DECEMBER 19, 2023
Ionis has signed a licence agreement under which Otsuka will gain sole rights to market donidalorsen for hereditary angioedema in Europe.
pharmaphorum
DECEMBER 19, 2023
In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Joel Morse, CEO and co-founder of Curavit Clinical Research, and Andy Molnar, CEO of the Digital Therapeutics Alliance (DTA), for a discussion on why it is that digital therapeutics (DTx) are effective and safe, but not being prescribed.
Pharmaceutical Technology
DECEMBER 19, 2023
The Gaucher disease market is expected to grow at a CAGR of 0.79%, reaching $1.3bn across 7MM by the end of this forecast period (2032).
BioSpace
DECEMBER 19, 2023
With an upfront payment of $185 million, GSK on Wednesday added another exclusive antibody-drug conjugate license agreement with China-based Hansoh Pharma.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharmaceutical Technology
DECEMBER 19, 2023
For the IBD market to grow, it is critical for biologics to continue to show efficacy over current biological/small-molecule therapies.
Pharma Times
DECEMBER 19, 2023
The BioMed X Institute and Ono Pharmaceutical have announced a new joint research collaboration for cancer research. The project, ‘New Strategies to Engage Neutrophils in Solid Tumors’, will help to design next-generation immunotherapies by advancing the antitumour effects of neutrophils. Neutrophils are a type of white blood cell that helps the immune system fight infections and heal injuries.
Pharmaceutical Technology
DECEMBER 19, 2023
Organon has signed a commercialisation agreement with Eli Lilly and Company for two migraine medicines, Emgality and RAYVOW, in Europe.
XTalks
DECEMBER 19, 2023
This year has been a pivotal year for the food industry, marked by intriguing developments, surprising trends and groundbreaking innovations. As we reflect on this dynamic year, it’s exciting to revisit the food news of 2023 that captivated our readers’ imaginations and sparked the most discussions. From the mystery of missing ingredients to the introduction of unconventional products, these top ten food news stories on Xtalks.com showcase the food industry’s resilience, innov
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
DECEMBER 19, 2023
BioNTech has inaugurated a new messenger RNA (mRNA) vaccine manufacturing facility in Kigali, Rwanda, which will have BioNTainers.
Outsourcing Pharma
DECEMBER 19, 2023
The US contract development and manufacturing organization (CDMO) Agno Pharma has taken over compatriot firm Lubrizol Particle Sciences to increase its drug product formulation offerings.
Pharmaceutical Technology
DECEMBER 19, 2023
The topline data announcement comes on the same day as Lilly further extends its tender offer for the acquisition of POINT.
Outsourcing Pharma
DECEMBER 19, 2023
The drug discovery specialist Anagenex has sealed a collaboration pact with Nimbus Therapeutics to co-develop small molecule drugs with the help of artificial intelligence (AI).
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
263 
Let's personalize your content